Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melenda D Jeter

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2017
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on SurvivalMiho Kono, Pamela K Allen, Steven H Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Potential dosimetric benefits of four-dimensional radiation treatment planningGeorge Starkschall, Keith Britton, Mary F McAleer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Gemcitabine-induced radiation recallMelenda D Jeter, Pasi A Jänne, Sarah Brooks, et al.
Cancer|May 28, 2009
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?Susan L McGovern, Zhongxing Liao, M Kara Bucci, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2017
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 StudyMelenda D Jeter, Daniel Gomez, Quynh-Nhu Nguyen, et al.
American Journal of Clinical Oncology|January 29, 2020
Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical TrialStephen G Chun, Zhongxing Liao, Melenda D Jeter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2007
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesotheliomaDavid C Rice, W Roy Smythe, Zhongxing Liao, et al.
The Lancet. Oncology|September 16, 2021
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgeryJoe Y Chang, Reza J Mehran, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2017
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on SurvivalMiho Kono, Pamela K Allen, Steven H Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Potential dosimetric benefits of four-dimensional radiation treatment planningGeorge Starkschall, Keith Britton, Mary F McAleer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Gemcitabine-induced radiation recallMelenda D Jeter, Pasi A Jänne, Sarah Brooks, et al.
Cancer|May 28, 2009
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?Susan L McGovern, Zhongxing Liao, M Kara Bucci, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2017
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 StudyMelenda D Jeter, Daniel Gomez, Quynh-Nhu Nguyen, et al.
American Journal of Clinical Oncology|January 29, 2020
Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical TrialStephen G Chun, Zhongxing Liao, Melenda D Jeter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2007
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesotheliomaDavid C Rice, W Roy Smythe, Zhongxing Liao, et al.
The Lancet. Oncology|September 16, 2021
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgeryJoe Y Chang, Reza J Mehran, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Pageof 2